about
Tuberculosis control: challenges of an ancient and ongoing epidemicOcular tuberculosis: current perspectivesHepatotoxicity from antituberculous therapy in the elderly: a systematic reviewSix months therapy for tuberculous meningitisMulti-drug resistant tuberculous spondylitis: A review of the literatureWhen tuberculosis comes back: who develops recurrent tuberculosis in california?Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistancePyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, CaliforniaEfficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled TrialTuberculosis control activities before and after Hurricane Sandy--northeast and mid-Atlantic states, 2012.Efficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis.Six-month therapy for abdominal tuberculosis.Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory.Personal and societal health quality lost to tuberculosis.Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.Antitubercular therapy in patients with cirrhosis: challenges and optionsZinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in IndonesiaTuberculosis and homelessness in the United States, 1994-2003.Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage AdjustmentsIn-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement.Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells.First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in KuwaitIsoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort studyTuberculosis and diabetes mellitus: convergence of two epidemics.RNTCP and tuberculosis control - High time to act.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theTuberculous prostatic abscess in an immunocompromised patient.High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis.Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction.Association between diabetes mellitus and tuberculosis in United States-born and foreign-born populations in San FranciscoAdverse reactions to antituberculosis drugs in Iranian tuberculosis patients.Current concepts in the management of tuberculosisSuperoxide Dismutase Gene (SOD1, SOD2, and SOD3) Polymorphisms and Antituberculosis Drug-induced Hepatitis.
P2860
Q26206908-6E2A0493-4108-4275-AE7C-D57BA8D5F7E5Q26773217-EDA73503-5F37-405E-BA93-996256DF014CQ27022370-B55AF8BA-8FFC-412D-A85F-81A24116B7A6Q28074247-B74DAF98-2820-46FB-B8D3-E8EECAA97E4EQ28078449-C9755CA3-D1A1-4C26-A11B-263114987D0EQ28393254-C9218470-2A2A-4F43-944D-C790FDFC07B0Q28537951-FA959006-0F94-4AAC-91A5-E9CCB0D9739FQ28538180-DC5F726B-74DA-43DE-B40A-0CD5E104A575Q28551970-679AC4DA-8CD8-44BF-8B0A-3F12126D5FC2Q30223240-BDD25F63-660D-4CCF-95C5-F745F93A3A10Q30239768-EF931554-0AA1-4AFD-B7C7-770A9A563D86Q30242077-4A291A42-7199-40EB-9945-8197CCB8BC5CQ30383012-6FA1DA48-D62E-4BF1-8408-3FCF6D0E2636Q30405961-658895AF-CE9F-40F5-A6F4-470941E8742AQ30414792-837A27EB-1029-41AE-89B6-193B23762B94Q33427787-F099E5EC-69E7-4AB8-8E7F-3CEC5B0A0A55Q33537398-CE61D564-B86A-404F-ACDB-63662CEED0B6Q33559021-B6731903-C7A7-49F2-930E-3954AA36C8B1Q33565674-8A459EA8-0635-4123-B8F1-17B0D5C68E18Q33626827-57DBD897-7F45-446A-853A-2C3171C683FDQ33709720-CC1FE3CB-6A3D-46B2-B87F-B0810664CA1AQ33746058-7177EB9C-A977-4BBF-86C6-65C70539F1B7Q33746114-9CEC2E52-65BC-4B88-8335-AEEFEE8A882DQ33763177-39315040-91F0-4E62-9ABB-CD64D0702954Q33825710-F0BA1093-9223-4DA8-9782-1D21335FFF02Q33836905-C45B5158-96D4-4C77-9F4C-69BD29D53714Q33872796-B1809E5E-FA9E-45C2-BB14-F3365056CC5FQ34125176-80328AD2-25E6-485B-B539-C3FA78C51AFEQ34156234-7ADDE8FA-917B-43AD-A7E8-2456FD232811Q34159923-C9ABF6AA-17F4-4C7A-A613-5E8C48089528Q34212799-8A16133E-0FFF-4F7C-AB23-A4FCA8E4962DQ34220861-70E7C2D0-98AD-4F15-AA25-758F0ABE58CCQ34444002-806A4912-6BFA-4216-862D-EA0D1FAF5D11Q34480176-123817F7-369A-4E98-870D-0D0DB7601833Q34489567-244749ED-9E2E-4E17-A5EC-14644C3D3E1CQ34565300-459BC052-0FA4-4389-9BE9-A0D059C1618CQ34640656-68AD5F0C-0BC6-498D-8BAA-1F1B16F62546Q34660150-72488F91-3B48-47D4-A084-C6D5A07AB1E7Q34748542-FE5EDA59-22EB-4C49-B5A8-057599528675Q34760618-28AE2560-3091-4823-9669-19BE88760018
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment of tuberculosis
@ast
Treatment of tuberculosis
@en
Treatment of tuberculosis
@nl
type
label
Treatment of tuberculosis
@ast
Treatment of tuberculosis
@en
Treatment of tuberculosis
@nl
prefLabel
Treatment of tuberculosis
@ast
Treatment of tuberculosis
@en
Treatment of tuberculosis
@nl
P50
P3181
P1476
Treatment of tuberculosis
@en
P3181
P407
P50
P577
2003-06-01T00:00:00Z